Bassi, Pierfrancesco
 Distribuzione geografica
Continente #
EU - Europa 13.276
NA - Nord America 7.083
AS - Asia 1.226
AF - Africa 50
SA - Sud America 39
Continente sconosciuto - Info sul continente non disponibili 19
OC - Oceania 8
Totale 21.701
Nazione #
US - Stati Uniti d'America 6.993
IT - Italia 6.678
DE - Germania 2.446
SE - Svezia 1.410
CN - Cina 798
UA - Ucraina 732
FR - Francia 576
IE - Irlanda 334
GB - Regno Unito 293
PL - Polonia 280
IN - India 227
FI - Finlandia 162
BE - Belgio 72
RU - Federazione Russa 68
TR - Turchia 64
CA - Canada 57
CH - Svizzera 52
NL - Olanda 38
ES - Italia 34
CI - Costa d'Avorio 32
JP - Giappone 29
RO - Romania 19
BR - Brasile 17
HK - Hong Kong 15
IR - Iran 15
SG - Singapore 15
KR - Corea 13
AT - Austria 12
BZ - Belize 12
EU - Europa 12
VN - Vietnam 12
AR - Argentina 10
CZ - Repubblica Ceca 9
MA - Marocco 9
GR - Grecia 8
PT - Portogallo 8
HU - Ungheria 7
MX - Messico 7
MY - Malesia 7
AL - Albania 6
DO - Repubblica Dominicana 6
PA - Panama 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AU - Australia 5
EC - Ecuador 4
ID - Indonesia 4
PH - Filippine 4
RS - Serbia 4
TH - Thailandia 4
CO - Colombia 3
HR - Croazia 3
IL - Israele 3
IS - Islanda 3
LU - Lussemburgo 3
MD - Moldavia 3
SM - San Marino 3
TN - Tunisia 3
TW - Taiwan 3
A1 - Anonimo 2
BD - Bangladesh 2
BG - Bulgaria 2
CL - Cile 2
IQ - Iraq 2
LK - Sri Lanka 2
LT - Lituania 2
NZ - Nuova Zelanda 2
PE - Perù 2
PK - Pakistan 2
SK - Slovacchia (Repubblica Slovacca) 2
UG - Uganda 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
CM - Camerun 1
CR - Costa Rica 1
DK - Danimarca 1
DZ - Algeria 1
EG - Egitto 1
HN - Honduras 1
JO - Giordania 1
KH - Cambogia 1
KZ - Kazakistan 1
LI - Liechtenstein 1
MC - Monaco 1
ME - Montenegro 1
NO - Norvegia 1
OM - Oman 1
PG - Papua Nuova Guinea 1
ZA - Sudafrica 1
Totale 21.701
Città #
Chandler 1.591
Milan 733
Rome 603
Ashburn 579
Jacksonville 423
San Mateo 328
Dublin 322
Ann Arbor 311
Nanjing 238
Wilmington 238
Warsaw 182
Naples 153
Dearborn 149
Houston 146
Woodbridge 143
New York 131
Bremen 127
Nanchang 122
Nürnberg 122
Florence 119
Munich 115
Lawrence 114
Los Angeles 112
Fairfield 105
Boston 101
Turin 101
Bologna 91
Cattolica 88
Marseille 87
Beijing 86
Redwood City 86
Kraków 83
Princeton 74
Bari 70
Seattle 69
Palermo 68
Brussels 61
Chicago 58
Lancaster 55
Mountain View 55
Verona 53
Genoa 52
Falls Church 50
Kunming 44
Padova 42
Catania 40
Izmir 40
Redmond 40
Boardman 37
Tianjin 36
Cambridge 35
Ottawa 35
University Park 34
Hebei 33
Abidjan 32
San Jose 31
Helsinki 30
Jiaxing 30
Norwalk 30
Brescia 29
Shenyang 28
Hangzhou 27
Venice 27
Cagliari 25
Changsha 25
Messina 23
Perugia 22
Salerno 21
Augusta 20
Reggio Emilia 20
Bergamo 19
Leawood 19
Saint Petersburg 19
Enterprise 18
Livorno 18
Changchun 17
Simi Valley 17
Taranto 17
Andover 16
Kiselëv 16
Pescara 16
Las Vegas 15
Novara 15
Shanghai 15
Parma 14
Pune 14
Washington 14
Albuquerque 13
Hefei 13
Philadelphia 13
Rimini 13
Trieste 13
Udine 13
Amsterdam 12
Belize City 12
Guangzhou 12
Jinan 12
London 12
Menlo Park 11
Miami 11
Totale 9.869
Nome #
Le disfunzioni sessuali maschili in pazienti con insufficienza renale cronica end stage ed in pazienti sottoposti a trapianto renale 4.290
Iniezione transuretrale intracervicale di tossina botulinica tipo A nel trattamento della dissinergia del collo vescicale refrattaria a terapia medica 827
Ruolo della risonanza magnetica funzionale (DCE-MRI, DWI-MRI)in pazienti sottoposti a saturation biopsy per persistente sospetto di carcinoma prostatico nonostante un primo set bioptico negativo: risultati preliminari su esperienza monocentrica 608
Iniezione intracervicale di OnabotulinotossinaA per il trattamento dell'ostruzione primitiva del collo vescicale refrattaria alla terapia medica. Una nuova opzione terapeutica 583
MALAT1 and HOTAIR long non-coding RNAs play opposite role in estrogen-mediated transcriptional regulation in prostate cancer cells 316
High intensity focused ultrasound (HIFU) in prostate cancer: today’s outcomes and tomorrow’s perspectives 292
Il ruolo della chemioimmunoterapia endovescicale nella neoplasia della vescica non muscolo invasiva “ non responder” 278
Studio trasversale sui sintomi e sulle complicanze del basso apparato urinario e sul loro impatto sulla qualità  della vita connessa alla salute (HRQL) in una coorte di pazienti con sclerosi multipla (MS) utilizzando questionari standardizzati 243
High-intensity focused ultrasound in prostate cancer: Today's outcomes and tomorrow's perspectives 243
La tecnologia robotica nel contesto urologico italiano: analisi economica costo-efficacia 239
Efficacia di un programma supervisionato perioperatorio di fisioterapia del pavimento pelvico per il miglioramento del recupero della continenza dopo prostatectomia radicale: trial randomizzato controllato 237
Pros-IT CNR: an Italian prostate cancer monitoring project 204
(99m)Tc-MAG3 diuretic renography in diagnosis of obstructive nephropathy in adults: a comparison between F-15 and a new procedure F+10(sp) in seated position 172
Efficacy of a supervised low-intensity regimen of perioperative pelvic floor muscle training in reducing postprostatectomy urinary incontinence: A randomized controlled trial 168
E-CADHERIN AND IL-6 SERUM LEVELS IN PATIENTS AFFECTED BY PROSTATE CANCER BEFORE AND AFTER PROSTATECTOMY 167
H19-Dependent Transcriptional Regulation of β3 and β4 Integrins Upon Estrogen and Hypoxia Favors Metastatic Potential in Prostate Cancer. 164
SEXUAL DYSFUNCTIONS IN PATIENTS AFFECTED BY MULTIPLE SCLEROSIS: EVALUATION IN A CONTEMPORARY COHORT FROM A REFERRAL CENTER 158
Le infezioni delle vie urinarie 156
Do testis germinal tumours express PTTG (Pituitary Transforminf Tumour Gene) 155
Soluble E-cadherin and IL-6 serum levels in patients affected by prostate cancer before and after prostatectomy 142
Sexual outcomes after organ potency-sparing surgery and glans reconstruction in patients with penile carcinoma 136
Role of SOCS3 evaluated by immunohistochemical analysis in a cohort of patients affected by prostate cancer: preliminary results 134
Evidenze microbiologiche in un singolo centro urologico 126
OnabotulinumtoxinA injection therapy in men with LUTS due to primary bladder-neck dysfunction: objective and patient-reported outcomes 125
Discovery history and clinical development of mirabegron for the treatment of overactive bladder and urinary incontinence 123
Efficacy of an assisted low-intensity programme of perioperative pelvic floor muscle training in improving the recovery of continence after radical prostatectomy: a randomized controlled trial 122
Complications of Extracorporeal Shock Wave Lithotripsy for Urinary Stones: To Know and to Manage Them–A Review 121
Chirurgia robotica per tutti 121
[Urinary peptides and calcium oxalate nephrolithiasis, a combined approach: MALDI-TOF mass spectrometry and MicroBCA Protein Assay] 119
The occult urothelial cancer 117
Le complicanze nella chirurgia urologica 116
Paraneoplastic Dermatomyositis Associated With Panurothelial Transitional Cell Carcinoma: A Case Report and Literature Review 116
[Overactive bladder syndrome: the social and economic perspective] 115
Urological complications following inguinal hernioplasty 115
(99m)Tc-Mag3 Diuretic Renography In Assessment Of Obstructive Uropathy. The New Test F+10sp: A Step Ahead In The Differential Diagnosis 113
Advanced bladder cancer: New agents and new approaches. A review 112
Male infertility: non-surgical therapy 112
Endourethral migration of a Hem-o-Lok Clip after robot-assisted laparoscopic radical prostatectomy 112
Hifu as first line salvage therapy in prostate cancer local relapse after radical prostatectomy: 4-year follow-up outcomes 112
Extracorporeal shockwave lithotripsy in pediatrics 111
Human factors in surgery: from Three Mile Island to the operating room 109
Silencing of GSTP1, a prostate cancer prognostic gene, by the estrogen receptor-β and endothelial nitric oxide synthase complex 109
Imaging in prostate cancer diagnosis: present role and future perspectives 108
Hot topics in urological health economics. A mini review 107
Brachytherapy in men with prostate cancer: update on indications and outcomes 107
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study 106
IMAGING IN BLADDER CANCER: PRESENT ROLE AND FUTURE PERPECTIVES.Totaro A, Pinto F, Brescia A, Racioppi M, Cappa E, D'Agostino D, Volpe A, Sacco E, Palermo G, Valentini AL, Bassi PF. 106
[Foreign bodies in urinary bladder: a clinical case] 105
Robot technology in the Italian Health-CARE system: cost-efficacy economic analysis 105
Meccanismo d'azione del bioconiugato idrosolubile paclitaxel-acido ialuronico su linee cellulari umane di tumore della vescica 104
L' era del PCA3: risultati preliminari di uno studio pragmatico monocentrico 104
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia treated with intraprostatica onabotulinumtoxinA: 3 month results of a prospective single-armed cohort study 103
KV7 channels in the human detrusor: channel modulator effects and gene and protein expression 103
Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior 101
Behavioural profile and human adaptation of survivors after radical cystectomy and ileal conduit 101
Positive surgical margins in nephron sparing surgery for renal cell carcinoma 100
Size of Bladder Cancers: Correlation among Different Types of Measurement 99
HER-2 immunohistochemical expression as prognostic marker in high-grade T1 bladder cancer (T1G3) 99
Imaging in prostate cancer staging: present role e future perspectives 98
Antibiotic prophylaxis in urology 98
NBI: results review 98
Clinical, pathological and molecular prognostic factors in prostate cancer decision-making process 97
Postoperative Quality of Life in Patients with Ileal Neobladder at Short-, Intermediate- and Long-Term Follow-Up 95
Germ Cell Neoplasia in situ (GCNIS) in Testis-Sparing Surgery (TSS) for Small Testicular Masses (STMs) 95
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study 94
Treatment of bladder neck dissynergia with transurethral injection of OnabotulinumtoxinA: objective and patient-reported results 93
The Clinical Use of Statistical Permutation Test Methodology: A Tool for Identifying Predictive Variables of Outcome 93
Metabolic reprogramming by malat1 depletion in prostate cancer 93
Advanced bladder cancer: New agents and new approaches. A review 92
Imaging of renal cell carcinoma: state of the art and recent advances 92
Current status of robotic urologic surgery in Italy 91
Imaging in prostate cancer staging: present role and future perspectives 91
Neutrophil gelatinase-associated lipocalin (NGAL) value changes before and after shock wave lithotripsy 91
Bradeion (SEPT4) as a Urinary Marker of Transitional Cell Bladder Cancer: A Real-Time Polymerase Chain Reaction Study of Gene Expression 90
Paclitaxel-hyaluronic acid for intravesical therapy of bacillus Calmette-Guérin refractory carcinoma in situ of the bladder: results of a phase I study 89
Is microsurgical technique really necessary in inguinal or sub-inguinal surgical treatment of varicocele? 88
Surgery for male urinary incontinence: where are we now and what is in the pipeline? 88
Bladder pain syndrome associated with highest impact on sexual function among women with lower urinary tract symptoms 86
High intensity focused ultrasound as first line salvage therapy in prostate cancer local relapse after radical prostatectomy: 4-year follow-up outcomes 86
Male sexual dysfunction in patients with chronic end-stage renal insufficiency and in renal transplant recipients 85
Inhibition of prostate efferent neurotransmission by amikacin 84
Thermochemotherapy for non-muscle-invasive bladder cancer: is there a chance to avoid early cystectomy? 84
Development of a questionnaire specifically for patients with Ileal Orthotopic Neobladder (IONB) 84
Paclitaxel-hyaluronic acid for intravesical therapy of bacillus Calmette-Guérin refractory carcinoma in situ of the bladder: results of a phase I study 83
Circumcision: history, religion and law 83
Therapeutic strategies in penile cancer: state of the art 83
[Innovative treatments of non muscle invasive bladder cancer] 83
Imaging in Prostate Cancer Diagnosis: Present Role and Future Perspectives. 83
Is extracorporeal shock wave lithotripsy in pediatrics a safe procedure? 82
Test F+10 SP: un nuovo metodo angioscintigrafico per la diagnosi dell'uropatia ostruttiva 82
Second-line intravesical therapy. What is the present role of device-assisted therapy? 82
ElectroMotive drug administration (EMDA) of Mitomycin C as first-line salvage therapy in high risk "bCG failure" non muscle invasive bladder cancer: 3 years follow-up outcomes 82
Value of Current Chemotherapy and Surgery in Advanced and Metastatic Bladder Cancer 81
T2-weighted hypointense lesions within prostate gland: Differential diagnosis using wash-in rate parameter on the basis of dynamic contrast-enhanced magnetic resonance imaging-Hystopatology correlations 81
T2-weighted hypointense lesions within prostate gland: Differential diagnosis using wash-in rate parameter on the basis of dynamic contrast-enhanced magnetic resonance imaging–Hystopatology correlations 79
Mitomycin C: new strategies to improve efficacy of a well-known therapy 79
Local relapse of prostate cancer after primary definitive treatment: the management 78
Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior 77
Imaging of renal cell carcinoma: state of the art and recent advances 77
The occult urothelial cancer 76
Totale 17.542
Categoria #
all - tutte 58.315
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.315


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019286 0 0 0 0 0 0 0 0 0 80 133 73
2019/20202.245 355 112 118 81 124 174 194 128 301 119 323 216
2020/20211.997 84 198 114 199 265 135 195 72 221 108 301 105
2021/20222.229 211 147 77 180 177 110 79 290 135 156 297 370
2022/20235.876 668 625 408 759 335 627 264 470 628 278 473 341
2023/20245.285 381 790 428 541 473 585 520 621 448 498 0 0
Totale 21.974